Skip to main content

Christopher Ellis Archives

Device helps heart patients ditch blood thinners

Feb. 7, 2019—For the first time in 27 years, Jerry Flowers is looking at life without using blood thinners, thanks to a small device that was implanted in his heart in a clinical trial at Vanderbilt Heart and Vascular Institute (VHVI).

Read more


VUMC testing device to reduce stroke risk in arrhythmia patients

Feb. 9, 2017—Vanderbilt University Medical Center (VUMC) is the first in the state to enroll patients in a clinical trial testing the effectiveness of the newest implantable device used to reduce stroke risk in patients with non-valvular atrial fibrillation (AF), the most common form of arrhythmia.

Read more


Device helps curb atrial fibrillation patients’ stroke risk

Aug. 25, 2016—Peggy Tubb doesn’t recall her exact reaction when she was told she could stop taking blood thinners to treat atrial fibrillation (AF), but the news changed her life.

Read more


Vanderbilt Heart offers alternative to blood thinners for atrial fibrillation

Jun. 17, 2015—Vanderbilt Heart and Vascular Institute now offers patients with atrial fibrillation (AF) an alternative treatment to reduce their risk of stroke, potentially avoiding the long-term use of blood thinners such as warfarin.

Read more


Heart Institute testing world’s tiniest pacemaker

Sep. 18, 2014—Vanderbilt Heart and Vascular Institute is participating in a global clinical trial to test the safety and efficacy of the world’s smallest pacemaker.

Read more


‘Envelope’ reduces cardiac implant infections

Aug. 8, 2013—Vanderbilt Heart and Vascular Institute is the first in the United States to use a new fully resorbable “envelope” that encloses implantable cardiac devices, such as pacemakers and internal cardioverter defibrillators (ICDs), and helps prevent surgical site infections.

Read more


New technique eases stroke risk for atrial fibrillation patients

Aug. 1, 2013—People with the most common irregular heart rhythm known as atrial fibrillation (AF) are at greater risk for stroke due to the formation of clots in the left atrial appendage (LAA), a small pouch which empties blood into the left atrium.

Read more


Patient undergoes surgical first to treat his arrhythmia

Apr. 11, 2013—The state of Michael Stanbery’s health was shocking.

Read more


Trial tests novel treatment for heart failure patients

May. 27, 2011—A new implantable device currently being studied gives heart failure patients the ability to monitor their heart and take action when their condition begins to worsen.

Read more


Recent Stories from VUMC News and Communications Publications

Our amazing skin

Vanderbilt Medicine

Our amazing skin

Biology and the beat

Vanderbilt Medicine

Biology and the beat

Community care

Vanderbilt Nurse

Community care

Survive and thrive

Hope

Survive and thrive

more